Agenus (AGEN) Current Deferred Revenue (2010 - 2026)
Agenus' (AGEN) quarterly Current Deferred Revenue came in at $1.1 million in Q1 2026, up 8064.29% year-on-year from $14000.0 in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.
Agenus (AGEN) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Agenus' Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- On a quarterly basis, Current Deferred Revenue rose 8064.29% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 8064.29% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, down 2.64% from the prior year.
- Current Deferred Revenue held at $1.1 million in Q1 2026 per AGEN's latest filing, from $1.1 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $14.2 million in Q2 2022 and bottomed at $9000.0 in Q2 2024.
- The 5-year median for Current Deferred Revenue is $1.2 million (2023), against an average of $5.0 million.
- Across the five-year window, Current Deferred Revenue tumbled 99.9% in 2024 and jumped 8064.29% in 2026, its largest moves.
- Year by year, Current Deferred Revenue stood at $12.3 million in 2022, then slumped by 90.54% to $1.2 million in 2023, then gained by 1.12% to $1.2 million in 2024, then dropped by 2.64% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
- Per Business Quant, the three latest AGEN Current Deferred Revenue figures stand at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $45000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 6.14 Mn |
| Jun 30, 2023 | 8.97 Mn |
| Mar 31, 2023 | 11.03 Mn |
| Dec 31, 2022 | 12.27 Mn |
| Sep 30, 2022 | 12.76 Mn |
| Jun 30, 2022 | 14.20 Mn |
| Mar 31, 2022 | 13.53 Mn |
| Dec 31, 2021 | 23.63 Mn |
| Sep 30, 2021 | 19.68 Mn |
| Jun 30, 2021 | 42.83 Mn |